BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Babraham Institute Adopts DNASTAR Lasergene Software


10/3/2013 10:16:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MADISON, Wisconsin – October 3, 2013 – DNASTAR today announced that the Babraham Institute has chosen DNASTAR Lasergene software as its primary sequence assembly and analysis software platform for researchers within its organization.

A spokesperson for the Babraham Institute said, “Many of our scientists have used Lasergene sequence analysis software for several years and been extremely satisfied with it. We believe it will help advance our research to have all of our scientists use consistent, effective software tools. That is why we decided to standardize our sequence analysis software with Lasergene. We took advantage of this opportunity to allow our team to have access to strong molecular biology software on a virtually unlimited basis at a very reasonable cost. This arrangement will help support our success in achieving our mission for many years to come.”

Tom Schwei, Vice President and General Manager of DNASTAR, stated, “We are pleased to have entered into this agreement with the Babraham Institute, which is committed to supporting lifelong health for individuals. This site license provides a uniform structure that will support scientists and staff at the Babraham Institute in all of their scientific research endeavors for many years to come. As we continue to develop our software, all scientists within the Institute will benefit by having immediate access to the most recent innovations in our products. We appreciate the trust placed in our software, support, and company by the Institute’s management and we look forward to continuing to meet their sequence assembly and analysis software needs in the future.”

Financial terms of the arrangement were not disclosed.

About DNASTAR DNASTAR, Inc., Madison, Wisconsin, (www.DNASTAR.com) is a pioneer in the development and sale of software used to increase life scientists’ productivity using their desktop computer or on the Amazon Cloud.

DNASTAR’s comprehensive software suite, Lasergene, supports molecular biologists, geneticists, and structural biologists in meeting virtually all of their DNA, RNA, and protein sequence needs, including Sanger and next-generation sequence assembly and analysis, protein sequence and structure analysis, and protein structure prediction with easy to use, affordable, flexible computer software.

About The Babraham Institute

The Babraham Institute, which receives strategic funding (a total of £32.1M in 2012-13) from the Biotechnology and Biological Sciences Research Council (BBSRC), undertakes international quality life sciences research to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. The Institute’s research provides greater understanding of the biological events that underlie the normal functions of cells and the implication of failure or abnormalities in these processes. Research focuses on signalling and genome regulation, particularly the interplay between the two and how epigenetic signals can influence important physiological adaptations during the lifespan of an organism. By determining how the body reacts to dietary and environmental stimuli and manages microbial and viral interactions, we aim to improve wellbeing and healthier ageing.

Contact

Tom Schwei

VP & General Manager

DNASTAR, Inc.

Telephone: 608-237-3082

U.S. Toll Free: 866-511-5090

toms@dnastar.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

DNASTAR
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES